Navigation Links
GeneNews Announces Second Quarter Results
Date:8/7/2008

----------------------------------------------

(2,482,716) (1,393,794) (4,320,086) (2,716,265)

Financing:

Net proceeds from

issue of

capital stock

Proceeds from

exercise of

employee stock

options 220,350 251,100 25,459

Net proceeds from

exercise of 2004

broker warrants -

Payments on long

term debt (145,256) (38,258) (288,156) (75,401)

-------------------------------------------------------------------------

75,094 (38,258) (37,056) (49,942)

Investments:

Additions to

capital assets (20,057) (1,168,630) (233,161) (1,277,031)

-------------------------------------------------------------------------

Increase (decrease)

in cash and cash

equivalents (2,427,679) (2,600,682) (4,590,303) (4,043,238)

Cash and cash

equivalents,

beginning of period 9,116,406 19,151,012 11,279,030 20,593,568

-------------------------------------------------------------------------

Cash and cash

equivalents, end

of period $ 6,688,727 $ 16,550,330 $ 6,688,727 $ 16,550,330

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Supplemental cash

flow information:

Interest received 27,999 137,213 123,957 232,700

Interest paid 28,172 1,538 58,700 4,191


'/>"/>
SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. GeneNews announces 2007 year end results
7. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
8. GeneNews Announces First Quarter Results
9. Genenews adds two members to its Board of Directors
10. GeneNews announces management changes to support commercialization of ColonSentry(TM)
11. GeneNews launches worlds first blood test for colorectal cancer screening
Post Your Comments:
*Name:
*Comment:
*Email: